Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

KRT8/KRT18/KRT19, Mouse, Clone: 2A4, Abnova™

Catalog No. 89111047 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-111-047 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-111-047 Supplier Abnova Corporation Supplier No. MAB2513
Add to Cart
Add to Cart

Mouse monoclonal antibody raised against native KRT8/KRT18/KRT19.

Specifications

Antigen KRT8/KRT18/KRT19
Applications Immunohistochemistry (Frozen), Western Blot
Classification Monoclonal
Clone 2A4
Conjugate Unconjugated
Description Mouse monoclonal antibody raised against native KRT8/KRT18/KRT19.
Dilution Western Blot (1:1000) The optimal working dilution should be determined by the end user.
Formulation In PBS (1% BSA, 0.09% sodium azide)
Gene Symbols LOC100152077
Host Species Mouse
Immunogen Native purified pig KRT8/KRT18/KRT19.
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 100152077/100126286/3880
Test Specificity This antibody recognizes cytokeratin nos. 8, 18 and 19 typical for simple epithelial cells. Monoclonal antibody to cytokeratin is derived from the hybridoma produced by fusion between myeloma cells and Balb/c spleen cells.
Target Species Human, Pig
Content And Storage Store at 4°C. Do not freeze.
Form Liquid
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.